Anna

GalaxySpace is a Chinese satellite manufacturer and satellite internet technology provider. Its low Earth orbit (LEO) strategy combines repeatable spacecraft production, internally developed communications hardware, and network validation with telecom partners.  The commercial significance lies in its attempt to make advanced satellites practical to manufacture, deploy, and integrate into customer operations. Its portfolio spans complete

Pharmaron is a China-based provider of drug research, development, and manufacturing services. It combines a contract research organization (CRO) with a contract development and manufacturing organization (CDMO), supporting pharmaceutical and biotechnology clients through discovery, preclinical testing, and clinical development. Its service portfolio covers small molecules, biologics, and cell and gene therapies. Its importance lies in

CNSA, the China National Space Administration, is China’s national space agency responsible for areas including civil space policy, exploration programs, and international cooperation. Its work connects scientific missions with industrial development, including dedicated oversight of commercial space.  China’s space progress offers a useful view of how the country develops complex technologies and organizes research partnerships.

Legend Biotech has grown from a Nanjing startup into what the company describes as the world’s largest standalone cell therapy company, with more than 10,000 patients treated with CARVYKTI as of December 2025. The company reported $1.9 billion in CARVYKTI net trade sales for full-year 2025 and achieved franchise profitability, a milestone that few biotech

Insilico Medicine is a global biotechnology company that uses generative AI to identify disease targets, design molecules, and advance drug candidates into human trials. Its lead candidate, rentosertib, reached Phase III patient dosing in September 2026.  The company offers a concrete case study of AI moving into pharmaceutical development, with China playing an important role

GenScript is a biotechnology group that supplies gene synthesis, protein and antibody research services, and drug development and manufacturing support through ProBio. Its portfolio also includes industrial enzymes through Bestzyme. It sells the picks and shovels of biotech: genes to order, proteins on demand, and factory capacity to make them at scale. The company offers

Mindray is a Chinese medical technology company headquartered in Shenzhen, and its recent progress shows why China’s high-end medtech sector deserves closer study. The company now competes across patient monitoring, ultrasound, diagnostics, anesthesia, critical care, surgery, and connected hospital technology.  In the first half of 2026, international business generated 53% of company revenue and grew

Is BeiGene a Chinese company?  The precise answer is: it is China-founded, but today’s corporate structure is global. BeiGene is no longer just a Chinese biotech story. In May 2025, the company completed a redomiciliation to Switzerland and rebranded as BeOne Medicines Ltd., a global oncology company with $5.3 billion in full-year 2025 revenue, a

LandSpace became the first company worldwide to reach orbit with a methane-fueled rocket in July 2023. By 2025, this Beijing-based launch provider has moved from that historic Zhuque-2 achievement to testing Zhuque-3, a stainless-steel reusable vehicle designed to compete directly with SpaceX’s Falcon 9.  That establishes a concrete recovery milestone. The next commercial test is